276 related articles for article (PubMed ID: 33183946)
21. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness.
Kozak K; H Smith P; Lowe DJE; Weinberger AH; Cooper ZD; Rabin RA; George TP
Am J Drug Alcohol Abuse; 2021 Sep; 47(5):535-547. PubMed ID: 34280058
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
Wu LT; Zhu H; Mannelli P; Swartz MS
Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
[TBL] [Abstract][Full Text] [Related]
23. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
Leadbeater BJ; Ames ME; Linden-Carmichael AN
Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoking quit ratios among adults in the USA with cannabis use and cannabis use disorders, 2002-2016.
Weinberger AH; Pacek LR; Wall MM; Gbedemah M; Lee J; Goodwin RD
Tob Control; 2020 Jan; 29(1):74-80. PubMed ID: 30952691
[TBL] [Abstract][Full Text] [Related]
25. Craving in patients with schizophrenia and cannabis use disorders.
Schnell T; Becker T; Thiel MC; Gouzoulis-Mayfrank E
Can J Psychiatry; 2013 Nov; 58(11):646-9. PubMed ID: 24246436
[TBL] [Abstract][Full Text] [Related]
26. Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States.
Lekoubou A; Fox J; Bishu KG; Ovbiagele B
Epilepsy Res; 2020 Jul; 163():106341. PubMed ID: 32361206
[TBL] [Abstract][Full Text] [Related]
27. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
Machielsen MWJ; Veltman DJ; van den Brink W; de Haan L
Schizophr Res; 2018 Apr; 194():32-38. PubMed ID: 28351544
[TBL] [Abstract][Full Text] [Related]
28. Comorbidity and temporal relations of alcohol and cannabis use disorders from youth through adulthood.
Duncan SC; Gau JM; Farmer RF; Seeley JR; Kosty DB; Lewinsohn PM
Drug Alcohol Depend; 2015 Apr; 149():80-6. PubMed ID: 25661697
[TBL] [Abstract][Full Text] [Related]
29. Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in-Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis.
Desai R; Ghadge N; Kanagala SG; Katukuri N; James A; Kadiyala A; Vutukuru SD; Kotharu M; Borzoo T; Nalla A; Vyas A; Priyadarshni S; Shalaby M; Khalife W
J Am Heart Assoc; 2024 Jul; 13(13):e032787. PubMed ID: 38934855
[TBL] [Abstract][Full Text] [Related]
30. Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls.
Olesen JA; Posselt CM; Poulsen CH; Nordentoft M; Hjorthøj C
Psychol Med; 2020 Feb; 50(3):499-506. PubMed ID: 30880659
[TBL] [Abstract][Full Text] [Related]
31. Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States.
Zhu H; Wu LT
J Addict Med; 2017; 11(5):357-367. PubMed ID: 28700366
[TBL] [Abstract][Full Text] [Related]
32. Cannabis use disorder trajectories and their prospective predictors in a large population-based sample of young Swiss men.
Marmet S; Studer J; Wicki M; Gmel G
Addiction; 2021 Mar; 116(3):560-570. PubMed ID: 32621560
[TBL] [Abstract][Full Text] [Related]
33. Association between cannabis use disorder and schizophrenia stronger in young males than in females.
Hjorthøj C; Compton W; Starzer M; Nordholm D; Einstein E; Erlangsen A; Nordentoft M; Volkow ND; Han B
Psychol Med; 2023 Nov; 53(15):7322-7328. PubMed ID: 37140715
[TBL] [Abstract][Full Text] [Related]
34. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.
Weinberger AH; Gbedemah M; Wall MM; Hasin DS; Zvolensky MJ; Goodwin RD
Addiction; 2018 Apr; 113(4):719-728. PubMed ID: 29265574
[TBL] [Abstract][Full Text] [Related]
35. Risk of readmission among individuals with cannabis use disorder during a 15-year cohort study: the impact of socio-economic factors and psychiatric comorbidity.
Rabiee R; Sjöqvist H; Agardh E; Lundin A; Danielsson AK
Addiction; 2023 Jul; 118(7):1295-1306. PubMed ID: 36746781
[TBL] [Abstract][Full Text] [Related]
36. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
37. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
38. Cannabis Use is an Independent Risk Factor for Manic Episode: A Report from 380,265 Bipolar Inpatients.
Patel RS; Cheema Z; Singla A; Cornejo M; Verma G
Subst Use Misuse; 2022; 57(3):344-349. PubMed ID: 34895014
[TBL] [Abstract][Full Text] [Related]
39. Identifying HIV care enrollees at-risk for cannabis use disorder.
Hartzler B; Carlini BH; Newville H; Crane HM; Eron JJ; Geng EH; Mathews WC; Mayer KH; Moore RD; Mugavero MJ; Napravnik S; Rodriguez B; Donovan DM
AIDS Care; 2017 Jul; 29(7):846-850. PubMed ID: 28006972
[TBL] [Abstract][Full Text] [Related]
40. A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies.
Kedzior KK; Laeber LT
BMC Psychiatry; 2014 May; 14():136. PubMed ID: 24884989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
